We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inspection of Pacira Plant Prompts EU Recall of Cancer Drug DepoCyte
Inspection of Pacira Plant Prompts EU Recall of Cancer Drug DepoCyte
September 10, 2012
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has urged Pacira Pharmaceuticals’ cancer drug DepoCyte be recalled in certain EU countries, citing “manufacturing deficiencies” found at the company’s San Diego, Calif., facility.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor